Replies to post #63192 on Therapeutic Solutions International Inc (TSOI)

[BigBadWolf]

Form S-1/A What this means as it relates to the original 555,000,000 immediately freely tradable No Rule 144 20% discounted shares w/ lowest pps look back clause.

https://www.otcmarkets.com/filing/html?id=17237897&guid=lAd-kpF5cwRSJth

We initially registered on Form S-1 (File No. 333-268070) (i) the issuance and sale of up to 555,000,000 shares of our Common Stock, par value $0.0001 per share (“Common Stock) offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 and pursuant to a securities purchase agreement which provides the right to an aggregate gross proceeds of up to $10.0 million from the sale of our Common Stock to the selling shareholder, GHS Investments, LLC (“GHS”) (the “GHS Purchase Agreement”) entered into on September 19, 2022. The S-1, as amended, became effective February 15, 2023.

https://www.businesswire.com/news/home/20220920005776/en/

As described in the Explanatory Notes above, to date GHS has been issued 541,632,207 shares of Common Stock vis-à-vis 12 noticed Puts so that 13,367,703 shares remain available as registered under the effective S-1 of Common Stock, and the total value of the remaining shares is $11,763.58 (at current market price) so that $9,219,567.99 remains available under the GHS Purchase Agreement.

Less that $800k for the 541,632,207 shares…when Dixon was touting $10m in financing for Therapeutic Solutions International Secures Financing to Complete Current Phase III Stem Cell Clinical Trial
https://www.businesswire.com/news/home/20220920005776/en/